Elekta AB (publ) EKTAF Stock
Elekta AB (publ) Price Chart
Elekta AB (publ) EKTAF Financial and Trading Overview
| Elekta AB (publ) stock price | 6.5 USD |
| Previous Close | 6.5 USD |
| Open | 6.5 USD |
| Bid | 5.45 USD x 80000 |
| Ask | 6.03 USD x 10000 |
| Day's Range | 6.5 - 6.5 USD |
| 52 Week Range | 4.48 - 6.83 USD |
| Volume | 1.34K USD |
| Avg. Volume | 52 USD |
| Market Cap | 2.48B USD |
| Beta (5Y Monthly) | 0.963 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.15 USD |
| Forward Dividend & Yield | 0.26 (4.01%) |
| Ex-Dividend Date | March 5, 2026 |
| 1y Target Est | N/A |
EKTAF Valuation Measures
| Enterprise Value | N/A |
| Trailing P/E | N/A |
| Forward P/E | 1.3052208 |
| PEG Ratio (5 yr expected) | 0.31 |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | 0.29394472 |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | N/A |
Trading Information
Elekta AB (publ) Stock Price History
| Beta (5Y Monthly) | 0.963 |
| 52-Week Change | 20.37% |
| S&P500 52-Week Change | 27.69% |
| 52 Week High | 6.83 USD |
| 52 Week Low | 4.48 USD |
| 50-Day Moving Average | 6.21 USD |
| 200-Day Moving Average | 5.76 USD |
EKTAF Share Statistics
| Avg. Volume (3 month) | 52 USD |
| Avg. Daily Volume (10-Days) | 300 USD |
| Shares Outstanding | 367.1M |
| Float | 318.7M |
| Short Ratio | N/A |
| % Held by Insiders | 1.92% |
| % Held by Institutions | 66.92% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | 333.00% |
| Payout Ratio | 3.1579 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | April 30, 2026 |
| Most Recent Quarter (mrq) | April 30, 2026 |
| Next Fiscal Year End | April 30, 2027 |
Profitability
| Profit Margin | -3.10% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 38.38% |
| EBITDA Margin | 8.57% |
Management Effectiveness
| Return on Assets (ttm) | 2.48% |
| Return on Equity (ttm) | -6.45% |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | -7.59% |
| Gross Profit (ttm) | N/A |
| EBITDA | 1.43B USD |
| Net Income Avi to Common (ttm) | N/A |
| Diluted EPS (ttm) | -0.15 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | N/A |
| Total Cash Per Share (mrq) | N/A |
| Total Debt (mrq) | N/A |
| Total Debt/Equity (mrq) | 102.56 USD |
| Current Ratio (mrq) | 0.87 |
| Book Value Per Share (mrq) | 22.113 |
Cash Flow Statement
| Operating Cash Flow (ttm) | N/A |
| Levered Free Cash Flow (ttm) | 1.12B USD |
Profile of Elekta AB (publ)
| Country | United States |
| State | N/A |
| City | Stockholm |
| Address | Hagaplan 4 |
| ZIP | 113 68 |
| Phone | 46 8 58 72 54 00 |
| Website | https://www.elekta.com |
| Industry | Medical Devices |
| Sector(s) | Healthcare |
| Full Time Employees | 4353 |
Elekta AB (publ), a medical technology company, provides clinical solutions for treating cancer and brain disorders in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company offers linear accelerator and radiation therapy products comprising Elekta Unity for anatomy-specific MR imaging; Elekta Evo that delivers offline and online adaptive radiation therapy; Elekta Versa HD, a brain metastases solution; Elekta Harmony; and Elekta Infinity for treating a range of patients with simple-to-complex radiotherapy needs, as well as quality assurance, and treatment and motion management solutions. It also provides stereotactic radiosurgery products, such as Elekta Esprit, a gamma knife system; and Leksell GammaPlan, a treatment planning and management software, as well as Elekta ONE, an oncology software suite. In addition, the company offers brachytherapy products, including Elekta Studio, an image-guided brachytherapy solution; ImagingRing for dynamic imaging; Oncentra Brachy, a smart tool that facilitates repetitive tasks; Elekta Xoft Axxent and electronic brachytherapy systems; Elekta Geneva, an applicator for cervical cancer patients; Elekta Flexitron afterloader for enabling the precise execution of all steps in the workflow; and Venezia applicator that enables the oncologist to treat locally advanced cervical cancer. Further, it provides Leksell Vantage Stereotactic System, a neurosurgery product; Elekta Kaiku for personalized cancer care; and veterinary radiation therapy solutions. Additionally, the company offers Elekta Care support services; Elekta Care 360, which provides a range of clinical and professional services; Elekta Care Learning that offers in-person and digital training courses on radiotherapy; Elekta Care Community, a self-help center; Elekta Partner Community, an online self-service portal; and Elekta Intellimax for predictive maintenance. Elekta AB (publ) was incorporated in 1972 and is headquartered in Stockholm, Sweden.
Q&A For Elekta AB (publ) Stock
What is a current EKTAF stock price?
Elekta AB (publ) EKTAF stock price today per share is 6.5 USD.
How to purchase Elekta AB (publ) stock?
You can buy EKTAF shares on the OTC Markets OTCPK exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Elekta AB (publ)?
The stock symbol or ticker of Elekta AB (publ) is EKTAF.
Which industry does the Elekta AB (publ) company belong to?
The Elekta AB (publ) industry is Medical Devices.
How many shares does Elekta AB (publ) have in circulation?
The max supply of Elekta AB (publ) shares is 382.08M.
What is Elekta AB (publ) Price to Earnings Ratio (PE Ratio)?
Elekta AB (publ) PE Ratio is now.
What was Elekta AB (publ) earnings per share over the trailing 12 months (TTM)?
Elekta AB (publ) EPS is -0.15 USD over the trailing 12 months.
Which sector does the Elekta AB (publ) company belong to?
The Elekta AB (publ) sector is Healthcare.


